These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33930398)

  • 1. Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease.
    Murray SJ; Russell KN; Melzer TR; Gray SJ; Heap SJ; Palmer DN; Mitchell NL
    Exp Eye Res; 2021 Jun; 207():108600. PubMed ID: 33930398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroretinography data from ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses.
    Russell KN; Mitchell NL; Wellby MP; Barrell GK; Palmer DN
    Data Brief; 2021 Aug; 37():107188. PubMed ID: 34141843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses.
    Murray SJ; Mitchell NL
    Sci Rep; 2022 Mar; 12(1):3670. PubMed ID: 35256654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal In Vivo Monitoring of the CNS Demonstrates the Efficacy of Gene Therapy in a Sheep Model of CLN5 Batten Disease.
    Mitchell NL; Russell KN; Wellby MP; Wicky HE; Schoderboeck L; Barrell GK; Melzer TR; Gray SJ; Hughes SM; Palmer DN
    Mol Ther; 2018 Oct; 26(10):2366-2378. PubMed ID: 30078766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual system pathology in a canine model of CLN5 neuronal ceroid lipofuscinosis.
    Kick GR; Meiman EJ; Sabol JC; Whiting REH; Ota-Kuroki J; Castaner LJ; Jensen CA; Katz ML
    Exp Eye Res; 2021 Sep; 210():108686. PubMed ID: 34216614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal gene therapy preserves retinal function in a canine model of CLN2 neuronal ceroid lipofuscinosis.
    Kick GR; Whiting REH; Ota-Kuroki J; Castaner LJ; Morgan-Jack B; Sabol JC; Meiman EJ; Ortiz F; Katz ML
    Exp Eye Res; 2023 Jan; 226():109344. PubMed ID: 36509165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
    Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
    Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease).
    Mitchell NL; Russell KN; Barrell GK; Tammen I; Palmer DN
    Dev Neurobiol; 2023; 83(5-6):127-142. PubMed ID: 37246363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis.
    Whiting REH; Pearce JW; Vansteenkiste DP; Bibi K; Lim S; Robinson Kick G; Castaner LJ; Sinclair J; Chandra S; Nguyen A; O'Neill CA; Katz ML
    Exp Eye Res; 2020 Aug; 197():108130. PubMed ID: 32622066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An EEG Investigation of Sleep Homeostasis in Healthy and CLN5 Batten Disease Affected Sheep.
    Perentos N; Martins AQ; Cumming RJ; Mitchell NL; Palmer DN; Sawiak SJ; Morton AJ
    J Neurosci; 2016 Aug; 36(31):8238-49. PubMed ID: 27488642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses.
    Russell KN; Mitchell NL; Anderson NG; Bunt CR; Wellby MP; Melzer TR; Barrell GK; Palmer DN
    Brain Behav; 2018 Sep; 8(9):e01096. PubMed ID: 30136763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal Injections in the Ovine Eye.
    Murray SJ; Mitchell NL
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35876543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal enzyme replacement inhibits progression of retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis.
    Whiting REH; Robinson Kick G; Ota-Kuroki J; Lim S; Castaner LJ; Jensen CA; Kowal J; Nguyen A; Corado C; O'Neill CA; Katz ML
    Exp Eye Res; 2020 Sep; 198():108135. PubMed ID: 32634395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal Degeneration In A Mouse Model Of CLN5 Disease Is Associated With Compromised Autophagy.
    Leinonen H; Keksa-Goldsteine V; Ragauskas S; Kohlmann P; Singh Y; Savchenko E; Puranen J; Malm T; Kalesnykas G; Koistinaho J; Tanila H; Kanninen KM
    Sci Rep; 2017 May; 7(1):1597. PubMed ID: 28487519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.
    Whiting REH; Jensen CA; Pearce JW; Gillespie LE; Bristow DE; Katz ML
    Exp Eye Res; 2016 May; 146():276-282. PubMed ID: 27039708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis.
    Murray SJ; Almuqbel MM; Felton SA; Palmer NJ; Myall DJ; Shoorangiz R; Ella A; Keller M; Palmer DN; Melzer TR; Mitchell NL
    Brain Commun; 2023; 5(1):fcac339. PubMed ID: 36632184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease.
    Kleine Holthaus SM; Herranz-Martin S; Massaro G; Aristorena M; Hoke J; Hughes MP; Maswood R; Semenyuk O; Basche M; Shah AZ; Klaska IP; Smith AJ; Mole SE; Rahim AA; Ali RR
    Hum Mol Genet; 2019 Dec; 28(23):3867-3879. PubMed ID: 31807779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of early changes in ovine CLN5 and CLN6 Batten disease neural cultures for the rapid screening of therapeutics.
    Best HL; Neverman NJ; Wicky HE; Mitchell NL; Leitch B; Hughes SM
    Neurobiol Dis; 2017 Apr; 100():62-74. PubMed ID: 28065762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Photoreceptor Cell Loss in a Cln6
    Kleine Holthaus SM; Ribeiro J; Abelleira-Hervas L; Pearson RA; Duran Y; Georgiadis A; Sampson RD; Rizzi M; Hoke J; Maswood R; Azam S; Luhmann UFO; Smith AJ; Mole SE; Ali RR
    Mol Ther; 2018 May; 26(5):1343-1353. PubMed ID: 29606505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Therapy Approaches to Treat the Neurodegeneration and Visual Failure in Neuronal Ceroid Lipofuscinoses.
    Kleine Holthaus SM; Smith AJ; Mole SE; Ali RR
    Adv Exp Med Biol; 2018; 1074():91-99. PubMed ID: 29721932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.